IL4 and Alzheimer disease: Activation of AhR signaling enhances the expression of skin barrier proteins like filaggrin and loricrin, while suppressing proinflammatory cytokines such as IL-4 and IL-13, thereby targeting two key AD mechanisms simultaneously [86].